CRAIF (CRAIF)
CRAIF (CRAIF)
Claim
Craif has developed a urinary biomarker discovery platform by capturing exosomes comprehensively from urine samples with microfabrication technology and by leveraging AI. With this innovative platform, Craif is proactively working to address various issues associated with cancer diagnosis and treatment.Craif has developed a urinary biomarker discovery platform by capturing exosomes comprehensively fro Show More
Alpha Score
$ 98.40 M
Alpha Score
71.9
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0